Medline, Inc. (MDLN)
35.39
-0.25
(-0.70%)
USD |
NASDAQ |
Aug 26, 11:50
Medline Cash from Operations (Quarterly) : 715.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 715.00M |
| March 31, 2026 | 412.00M |
| December 31, 2025 | 229.00M |
| September 30, 2025 | 636.00M |
| June 30, 2025 | 243.00M |
| Date | Value |
|---|---|
| March 31, 2025 | 636.00M |
| December 31, 2024 | -73.00M |
| September 30, 2024 | 722.00M |
| June 30, 2024 | 398.00M |
| March 31, 2024 | 722.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ICU Medical, Inc. | 80.15M |
| Insulet Corp. | 88.50M |
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | 17.45M |
| Alphatec Holdings, Inc. | 20.51M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -461.00M |
| Cash from Financing (Quarterly) | -159.00M |
| Free Cash Flow | 1.546B |
| Free Cash Flow Per Share (Quarterly) | 0.7016 |
| Free Cash Flow to Equity (Quarterly) | 601.00M |
| Free Cash Flow to Firm (Quarterly) | 698.05M |
| Free Cash Flow Yield | 5.30% |